1-10 of 10
Stéphane De Botton
Close
Sort by
Journal Articles

Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries

María Díez-Campelo, MD, PhD, Raphael Itzykson, Silvia M Rojas, Céline Berthon, MD, PhD, Elisa Luño, Odile Beyne-Rauzy, Jaime Perez-Oteyza, Norbert Vey, MD, PhD, Joan Bargay, Sophie Park, Teresa Cedena, Dominique Bordessoule, MD, PhD, Juan A Muñoz, Emmanuel Gyan, MD, PhD, Esperanza Such, Sorin Visanica, MD, Luis Benlloch, Stéphane de Botton, MD, PhD, Jesús M Hernández-Rivas, Shanti Ame, MD, Aspasia Stamatoullas, MD, Jacques Delaunay, MD, Celia Salanoubat, MD, Françoise Isnard, MD, Guillermo Sanz, Romain Guieze, MD, Consuelo Cañizo, MD, PhD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1713.
https://doi.org/10.1182/blood.V120.21.1713.1713
Published: 2012
Journal Articles

Use of Clofarabine in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Adults: The French Experience

David Sibon, MD, PhD, Ana Berceanu, MD, David Ghez, MD, PhD, Frantz Foissac, Leila Kammoun, MD, Thorsten Braun, MD, Denis Caillot, MD, Mario Ojeda-Uribe, MD, Romain Guieze, MD, Céline Berthon, MD, Laurence Sanhes, MD, Bérengère Gruson, MD, Didier Bouscary, MD, PhD, Christian Recher, MD, PhD, Laure Stalnikiewicz, MD, Philippe Rousselot, MD, PhD, Emmanuel Raffoux, MD, PhD, Thomas Prebet, MD, PhD, Bruno Salles, MD, Stéphane de Botton, MD, PhD, Ambroise Marcais, MD, Felipe Suarez, MD, PhD, Olivier Hermine, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2623.
https://doi.org/10.1182/blood.V118.21.2623.2623
Published: 2011
Journal Articles

Azacytidine (AZA) In Relapsed MDS and AML After Allogeneic Stem Cell Transplantation (allo-HSCT): Results of the French ATU Program.

Romain Guièze, Anne Jouinot, Raphael Itzykson, Sylvain Thepot, Thierry Guillaume, Valérie Coiteux, Sébastien Wittnebel, Stéphane de Botton, Caroline Dartigeas, Anne Sirvent, Pascal Turlure, Didier Bouscary, Marie Robin, Jean-Paul Vernant, Laurent Sutton, Francois Dreyfus, Jacques-Olivier Bay, Lionel Ades, Pierre Fenaux
Journal: Blood
Blood (2010) 116 (21): 1293.
https://doi.org/10.1182/blood.V116.21.1293.1293
Published: 2010
Journal Articles

Long-Term Outcome Associated with Current Allogeneic Stem Cell Transplantation Procedures In Younger Adults with Adverse-Risk AML In First CR – A Real-Life Transplant Versus No-Transplant Analysis of the Acute Leukemia French Association (ALFA)

Marie-Anne Hospital, Xavier Thomas, Sylvie Castaigne, Emmanuel Raffoux, Sébastien Maury, Claude Gardin, Jean-Henri Bourhis, Oumedaly Reman, Stéphane de Botton, Thierry de Revel, Christine Terré, Claude Preudhomme, Cécile Pautas, Pierre Fenaux, MD, PhD, Mauricette Michallet, Gérard Socié, Hervé Dombret, M.D.
Journal: Blood
Blood (2010) 116 (21): 3513.
https://doi.org/10.1182/blood.V116.21.3513.3513
Published: 2010
Journal Articles

Feasibility and Safety Profile of Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Younger Patients with AML in First Complete Remission (AML-CR1).

Ida Lobe, Nicolas Boissel, Emmanuel Raffoux, Adrienne de Labarthe, Cécile Pautas, Stéphane de Botton, Xavier Thomas, Hervé Dombret
Journal: Blood
Blood (2007) 110 (11): 1853.
https://doi.org/10.1182/blood.V110.11.1853.1853
Published: 2007
Journal Articles

Treatment of High Risk MDS and AML Post-MDS with Azacytidine (AZA): Preliminary Results of the French ATU Program.

Claire Fabre, MD, Fatsiha Chermat, Laurence Legros, MD, Sophie Park, MD, François Dreyfus, MD, Françoise Isnard, MD, Florence Nowak, MD, Anne Marfaing, MD, Stéphane de Botton, MD, Marie-Pierre Noel, MD, Christophe Fruchart, MD, Thomas Prebet, MD, Norbert Vey, MD, Caroline Dartigeas, MD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2006) 108 (11): 2664.
https://doi.org/10.1182/blood.V108.11.2664.2664
Published: 2006
Journal Articles

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Charikleia Kelaidi, MD, Sophie Park, MD, Sabine Brechignac, MD, Lionel Mannone, MD, Norbert Vey, MD, Herve Dombret, MD, Lina Aljassem, MD, Aspasia Stamatoullas, MD, Lionel Adès, MD, Stéphane Giraudier, MD, Stéphane de Botton, MD, Béatrice Mahé, MD, Pascale Lepelley, MD, Françoise Picard, MD, Geneviève Leroux, MD, Marie-Thérèse Daniel, MD, Didier Bouscary, MD, François Dreyfus, MD, Pierre Fenaux, MD
Journal: Blood
Blood (2006) 108 (11): 2678.
https://doi.org/10.1182/blood.V108.11.2678.2678
Published: 2006
Journal Articles

Post-Remission Therapy with Imatinib and HAM Improve MRD before Tansplant for Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL): Results of the GRAALL AFR03 Study.

Thibaut Leguay, MD, Francis Witz, MD, Stéphane De Botton, MD, Jean Gabert, MD PHD, Jean-Michel Cayuela, MD PHD, Elizabeth Macintyre, MD PHD, Claude Preudhomme, MD, Nathalie Fegueux, MD, Xavier Thomas, MD, Jean-Yves Cahn, MD, Martine Escoffre, MD, Andre Delannoy, MD, Norbert Ifrah, MD, Herve Dombret, MD, Arnaud Pigneux, MD
Journal: Blood
Blood (2006) 108 (11): 1877.
https://doi.org/10.1182/blood.V108.11.1877.1877
Published: 2006
Journal Articles

Are PU.1 mutations frequent genetic events in acute myeloid leukemia (AML)?

Charlotte Lamandin, Christophe Sagot, Christophe Roumier, Pascale Lepelley, Stéphane De Botton, Alain Cosson, Pierre Fenaux, Claude Preudhomme
Journal: Blood
Blood (2002) 100 (13): 4680.
https://doi.org/10.1182/blood-2002-08-2563
Published: 2002
Journal Articles

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

Clinical Trials & Observations
Claude Preudhomme, Christophe Sagot, Nicolas Boissel, Jean-Michel Cayuela, Isabelle Tigaud, Stéphane de Botton, Xavier Thomas, Emmanuel Raffoux, Charlotte Lamandin, Sylvie Castaigne, Pierre Fenaux, Hervé Dombret
Journal: Blood
Blood (2002) 100 (8): 2717–2723.
https://doi.org/10.1182/blood-2002-03-0990
Published: 2002